Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Lactobacillus plantarum isolated from leaves of Camellia sinensis
US9889167B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9889167-B2 |
| Application number | US-201615097854-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 13, 2016 |
| Priority date | Jun 10, 2011 |
| Publication date | Feb 13, 2018 |
| Grant date | Feb 13, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating diarrhea, said method comprising administering an effective dose of Lactobacillus plantarum APsulloc 331266 (Accession No. KCCM11181P) strain, an extract thereof, or a culture solution thereof to a subject in need of treating the diarrhea, wherein the strain has acid resistance at pH 2 to 4, wherein the strain has bile resistance at 0.3-0.5% bile concentration, wherein the strain ferments D-turanose but does not ferment rhamnose, inulin, or xylitol, wherein the strain produces D-type lactic acid in an amount of 70% or less based on a sum of amounts of the D-type lactic acid and L-type lactic acid produced. 2. The method according to claim 1 , wherein the strain, the extract thereof, or the culture solution thereof is administered in a composition, wherein the composition further comprises at least one of a surfactant, excipient, wetting agent, emulsifier, suspending agent, salt or buffer for osmotic pressure control, colorant, flavoring agent, stabilizer, preservative, and preserved agent. 3. The method according to claim 1 , wherein the strain is isolated from tea tree ( Camellia sinensis ) leaves. 4. The method according to claim 1 , wherein the strain has acid resistance at pH 2 to pH 4 for 0.5 hour to 5 hours. 5. The method of claim 1 , wherein the effective dose is 0.1 mg/kg/day to 5000 mg/kg/day. 6. The method of claim 1 , wherein administration is oral or parenteral.
Assignees
Inventors
Classifications
- A61K35/747Primary
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Microorganisms (addition of bacteria for nutritional purposes A23L33/135) · CPC title
Laxatives · CPC title
Antidiarrhoeals · CPC title
Bacteria; Culture media therefor · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9889167B2 cover?
- Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.
- Who is the assignee on this patent?
- Amorepacific Corp
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).